Compare TGB & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGB | PRGO |
|---|---|---|
| Founded | 1966 | 1887 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2002 | 2013 |
| Metric | TGB | PRGO |
|---|---|---|
| Price | $6.76 | $10.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $5.00 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 5.0M | 3.8M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.69% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | $67.93 | N/A |
| Revenue Next Year | $24.16 | $1.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.67 | $9.23 |
| 52 Week High | $9.25 | $28.44 |
| Indicator | TGB | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 47.08 |
| Support Level | $5.36 | $9.24 |
| Resistance Level | $9.08 | $15.08 |
| Average True Range (ATR) | 0.35 | 0.53 |
| MACD | 0.11 | 0.30 |
| Stochastic Oscillator | 89.86 | 64.25 |
Taseko Mines Ltd is a copper-focused mining company engaged in acquiring, developing, and operating large tonnage mineral deposits in stable jurisdictions that are capable of supporting a mine. Its principal assets are the wholly-owned Gibraltar mine (Gibraltar), which is located in central British Columbia (BC), and the Florence Copper mine, located in Arizona. Taseko also owns the Yellowhead copper, New Prosperity copper-gold, and Aley niobium projects in British Columbia, Canada.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.